ROBERT FELL: Open Payments
NPI 1366502817 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 21 payments from 8 companies in 2025. Trend: 2023 $2,307 · 2024 $1,403 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| ABBVIE INC. | 5 | $100 |
| Aimmune Therapeutics, Inc. | 5 | $83 |
| PFIZER INC. | 3 | $67 |
| Janssen Biotech, Inc. | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| VIVUS LLC | 1 | $13 |
Products named: ENTYVIO, LINZESS, VOWST, XELJANZ, TREMFYA, RINVOQ, OCALIVA, PILLCAM.
Industry payments across FL — which companies pay providers there.
